Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 47

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 47
---
 thereof or regulations promulgated thereunder (“FATCA”), any intergovernmental agreement between the United States and any other jurisdiction to implement FATCA, any law, regulation or other official guidance enacted or published in any jurisdiction implementing FATCA or an intergovernmental agreement with respect thereto, or any agreement with the U.S. Internal Revenue Service under FATCA (including any agreement described in Code Section 1471(b)), and we will not be required to pay Additional Amounts on account of any FATCA withholding Tax. In addition to the foregoing, we will also pay and indemnify the holder for any present or future stamp, stamp duty, stamp duty reserve tax, issue, registration, transfer, court or documentary taxes, or any other excise or property taxes, charges or similar levies (including penalties and interest related thereto) that are levied by any Relevant Tax

S-27

TABLE OF CONTENTS

Jurisdiction on the execution, delivery, issuance, or registration of any of the notes, ADSs (and ordinary shares represented thereby upon conversion of the notes), the indenture or any other document or instrument referred to therein, or the receipt of any payments with respect to, or enforcement of, the notes (other than, in each case, in connection with a transfer of notes after the initial sale by us of the notes or the delivery of ADSs in a name other than the name of the converting holder). We will timely make all withholdings and deductions required by law and will remit the full amount deducted or withheld to the relevant Tax authority in accordance with applicable law. We will furnish to the trustee (or to a holder upon request), within a reasonable time after the date the payment of any Taxes so deducted or withheld is made, certified copies of Tax receipts evidencing payment by us, as appropriate, or if receipts are not reasonably available, other evidence of payment reasonably satisfactory to the trustee. Whenever in the indenture or in this “Description of Notes” there is mentioned, in any context, payment of amounts based upon the principal amount of the notes or of principal, interest, optional redemption price, tax redemption price, fundamental change repurchase price, or of any other amount payable in cash under, or with respect to, any of the notes (other than payments in cash in lieu of delivery of ADSs as described under the caption “—Conversion Share Limitations” and payments of cash for any fractional ADS as described under the caption “—Settlement upon Conversion”) such mention shall be deemed to include